Contact us : info@bioworlde.com
Home > Product > Primary Antibodies
eIF4E (Phospho-S209) polyclonal antibody BS94012
  • Western blot analysis of Phospho-eIF4E(S209) on different lysates using anti-Phospho-eIF4E(S209) antibody at 1/1,000 dilution. Positive control: Lane 1: Mouse spleen Lane 2: Rat spleen
  • ICC staining Phospho-eIF4E(S209) in N2A cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Product NameeIF4E (Phospho-S209) polyclonal antibody
Catalog No.BS94012
Swiss-ProtP06730(Human) P63073(Mouse) P63074(Rat)
Host Rabbit
ReactivityHuman, Mouse, Rat
ApplicationsWB ICC IHC IP
Application_allWB:1:1,000-1:5,000 ICC:1:50-1:200 IHC:1:50-1:200
BiowMW25 kDa
Alternative NameeIF-4E, eIF4E, EIF4E, AUTS19, CBP, eIF 4E, eIF 4F 25 kDa subunit, EIF 4F, eIF-4E, eIF-4F 25 kDa subunit, eIF4E, EIF4E1, EIF4EL1, EIF4F, Eukaryotic translation initiation factor 4 E, Eukaryotic translation initiation factor 4E, Eukaryotic translation initiation factor 4E like 1, IF4E, Messanger RNA Cap Binding Protein eIF 4E, MGC111573, mRNA cap binding protein, mRNA cap-binding protein,
Purification&PurityProA affinity purified
ConjugateUnconjugated
ModificationPhosphorylation
Browse similar products>>
Size Price
50ul $258
100ul $398
Add to cart My orders
Product Name :
eIF4E (Phospho-S209) polyclonal antibody
Background :
The initiation of protein synthesis in eukaryotic cells is regulated by interactions between protein initiation factors and RNA molecules. The eukaryotic initiation complex eIF4F exists in vitro as a trimeric complex of eIF4E, eIF4A and eIF4G. Together, the complex allows ribosome binding to mRNA by inducing the unwinding of mRNA secondary structures. eIF4E binds to the mRNA "cap" during an early step in the initiation of protein synthesis. eIF4A acts as an ATP-dependent RNA helicase. eIF4G acts as a bridge between eIF4E, eIF4A and the eIF3 complex.
Product :
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Storage&Stability :
Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Specificity :
eIF4E (Phospho-S209) polyclonal antibody detects endogenous levels of eIF4E protein only when phosphorylated at S209.
Immunogen :
Synthetic phospho-peptide corresponding to residues surrounding Ser209 of human eIF4E.
Conjugate :
Unconjugated
Modification :
Phosphorylation
  • Western blot analysis of Phospho-eIF4E(S209) on different lysates using anti-Phospho-eIF4E(S209) antibody at 1/1,000 dilution. Positive control: Lane 1: Mouse spleen Lane 2: Rat spleen
  • ICC staining Phospho-eIF4E(S209) in N2A cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Bioworld Biotech only provide peptides for our antibodies and do not provide additional peptide customization services.

Price/Size :

USD 368/1mg/vial



Tips: 

For phospho antibody, we provide phospho peptide(0.5mg) and non-phospho peptide(0.5mg).

Describe :

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (WB) and Immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or IHC performed with the neutralized antibody.

Formula:

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.The purity is >90%,tested by HPLC and MS.

Storage:

The freeze-dried powder is more stable. For short time at 2-8°C. For long term storage store at -20°C. 


Note :

This product is for research use only (RUO only). Not for use in diagnostic or therapeutic procedures.
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER